REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro Especializado En Enfermedades Del Seno Ips Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Diagnostic Imaging Centers | Other Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: Centro Especializado En Enfermedades Del Seno Ips Sas Profile Updated: August 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Centro Especializado En Enfermedades Del Seno Ips Sas is an enterprise in Colombia, with the main office in Cucuta. The company operates in the Ambulatory Health Care Services industry. It was first established on August 13, 2018. The company’s latest financial report indicates a net sales revenue increase of 9.84% in 2022. There was a total negative growth of 0.93% in Centro Especializado En Enfermedades Del Seno Ips Sas’s total assets over the same period. The net profit margin of Centro Especializado En Enfermedades Del Seno Ips Sas decreased by 1.88% in 2022.

Headquarters
Av 0A No 20 - 38
Cucuta; Norte de Santander;

Contact Details: Purchase the Centro Especializado En Enfermedades Del Seno Ips Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centro Especializado En Enfermedades Del Seno Ips Sas report to view the information.
Incorporation Date:
August 13, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro Especializado En Enfermedades Del Seno Ips Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
9.84%
Total operating revenue
9.84%
Operating profit (EBIT)
-20.06%
EBITDA
-39.48%
Net Profit (Loss) for the Period
-47.95%
Total assets
-0.93%
Total equity
-2.06%
Operating Profit Margin (ROS)
-5%
Net Profit Margin
-1.88%
Return on Equity (ROE)
-2.36%
Quick Ratio
-0.56%
Cash Ratio
-0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?